- Home
- CPRX vs RNG Comparison
CPRX vs RNG Comparison
Compare CPRX & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- RNG
- Stock Information
- Founded
- CPRX 2002
- RNG 1999
- Country
- CPRX United States
- RNG United States
- Employees
- CPRX N/A
- RNG N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- RNG EDP Services
- Sector
- CPRX Health Care
- RNG Technology
- Exchange
- CPRX Nasdaq
- RNG Nasdaq
- Market Cap
- CPRX 2.6B
- RNG N/A
- IPO Year
- CPRX 2006
- RNG 2013
- Fundamental
- Price
- CPRX $24.69
- RNG $25.56
- Analyst Decision
- CPRX Strong Buy
- RNG Buy
- Analyst Count
- CPRX 8
- RNG 13
- Target Price
- CPRX $32.50
- RNG $37.69
- AVG Volume (30 Days)
- CPRX 1.5M
- RNG 1.9M
- Earning Date
- CPRX 05-07-2025
- RNG 05-06-2025
- Dividend Yield
- CPRX N/A
- RNG N/A
- EPS Growth
- CPRX 107.94
- RNG N/A
- EPS
- CPRX 1.31
- RNG N/A
- Revenue
- CPRX $491,734,000.00
- RNG $2,400,395,000.00
- Revenue This Year
- CPRX $15.17
- RNG $6.11
- Revenue Next Year
- CPRX $8.28
- RNG $6.05
- P/E Ratio
- CPRX $18.96
- RNG N/A
- Revenue Growth
- CPRX 23.49
- RNG 8.99
- 52 Week Low
- CPRX $14.47
- RNG $25.47
- 52 Week High
- CPRX $26.16
- RNG $42.19
- Technical
- Relative Strength Index (RSI)
- CPRX 62.78
- RNG 28.97
- Support Level
- CPRX $20.68
- RNG $26.68
- Resistance Level
- CPRX $26.16
- RNG $28.49
- Average True Range (ATR)
- CPRX 0.83
- RNG 0.73
- MACD
- CPRX 0.36
- RNG 0.18
- Stochastic Oscillator
- CPRX 75.21
- RNG 2.98
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.